SJ
Sanket Jatin Gandhi
About Sanket Jatin Gandhi
Data last updated:
Sanket Jatin Gandhi is a Director at Abil Chempharma Private Limited (since 2023). The companies operate in Pharma. Abil Chempharma Private Limited reported revenue of ₹795 Cr (FY 2025). Earlier, Sanket Jatin Gandhi was an Additional Director at Abil Chempharma Private Limited (2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Aug 2023 | 2002 | ₹795 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 21 Aug 2023 | 2002 | ₹795 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanket Jatin Gandhi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jayesh Ajit Paurana | 11651706 | Abil Chempharma Private Limited | Additional Director |
| Tejas Champaklal Shah | 01499314 | Abil Chempharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanket Jatin Gandhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanket Jatin Gandhi
Sanket Jatin Gandhi currently holds 1 directorship: Abil Chempharma Private Limited (Director, since 21 Aug 2023, revenue ₹795 Cr (FY 2025)).
Sanket Jatin Gandhi was first appointed on 21 Aug 2023 as Director at Abil Chempharma Private Limited.
Sanket Jatin Gandhi held 1 earlier board appointment: Abil Chempharma Private Limited (Additional Director, 21 Aug 2023 to 29 Sep 2023).
The current boards of Sanket Jatin Gandhi's companies include Jayesh Ajit Paurana (Abil Chempharma Private Limited), Tejas Champaklal Shah (Abil Chempharma Private Limited).